Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Promoter Polymorphisms of ST3GAL4 and ST6GAL1 Genes and Associations with Risk of Premalignant and Malignant Lesions of the Cervix

  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sialyltransferase gene expression is altered in several cancers, including examples in the cervix. Transcriptional regulation of the responsible genes depends on different promoters. We aimed to determine the association of single-nucleotide polymorphisms in the B3 promoter of the ST3GAL4 gene and the P1 promoter of the ST6GAL1 gene with cervical premalignant lesions or cervical cancer. A blood sample and/or cervical scrapes were obtained from 104 women with normal cytology, 154 with premalignant lesions and 100 with cervical cancer. We also included 119 blood samples of random donors. The polymorphisms were identified by sequencing from PCR products. For the B3 promoter, a fragment of 506 bp (from nucleotide -408 to +98) was analyzed, and for the P1 promoter a 490 bp (-326 to +164) fragment. The polymorphism analysis showed that at SNP rs10893506, genotypes CC and CT of the ST3GAL4 B3 promoter were associated with the presence of premalignant lesions (OR=2.89; 95%CI 1.72-4.85) and cervical cancer (OR=2.23; 95%CI 1.27-3.91). We detected only one allele of each polymorphism in the ST6GAL1 P1 promoter. We did not detect any genetic variability in the P1 promoter region in our study population. Our results suggest that the rs10893506 polymorphism -22C/T may increase susceptibility to premalignant and malignant lesions of the cervix.

Keywords

References

  1. Aasheim HC, Aas-Enh DA, Deggerdal A, et al (1993). Cell-specific expression of human beta galactoside ${\alpha}2,6$ sialyltransferase transcripts differing in the 5'untranslated region. Eur J Biochem, 213, 467-75. https://doi.org/10.1111/j.1432-1033.1993.tb17783.x
  2. Appenheimer MM, Huang RY, Chandrasekaran EV, et al. (2003). Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiol, 13, 591-600. https://doi.org/10.1093/glycob/cwg066
  3. Arai M, Yamada K, Toyota T, et al (2006). Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia, Biol Psychiatry, 59, 652-9. https://doi.org/10.1016/j.biopsych.2005.08.016
  4. Bull C, Boltje TJ, Wassink M, et al (2013). Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth. Mol Cancer Ther, 12, 1-12. https://doi.org/10.1186/1476-4598-12-1
  5. Christie DR, Shaikh FM, Lucas JA IV, Lucas JA III, Bellis SL (2008). ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res, 1, 1-8. https://doi.org/10.1186/1757-2215-1-1
  6. Fukasawa T, Asao T, Yamauchi H, et al (2013). Associated expression of ${\alpha}2,3$ sialylated type 2 chain structures with lymph node metastasis in distal colorectal cancer. Surg Today, 43, 155-62. https://doi.org/10.1007/s00595-012-0141-9
  7. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, et al (2001). The human sialyltransferases family. Biochimie, 83, 727-37. https://doi.org/10.1016/S0300-9084(01)01301-3
  8. Hilger-Eversheim K, Moser M, Schorle H, Buettner R (2000). Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene, 260, 1-12. https://doi.org/10.1016/S0378-1119(00)00454-6
  9. Jiang P, Liu J, Zeng X, Li W, Tang J (2010). MDM2 Gene Promoter Polymorphism and Risk of Cervical Cancer in Chinese Population. Bioinformatics Biomed Eng, 4, 2-4.
  10. Kitagawa H, Mattei MG, Paulson JC (1996). Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2, 3-sialyltransferase. J Biol Chem, 271, 931-8. https://doi.org/10.1074/jbc.271.2.931
  11. Li GS, Zhu L, Zhang H, et al (2007). Variants of the ST6GALNAC2 promoter influence transcriptional activity and contribute to genetic susceptibility to IgA nephropathy. Hum Mutat, 10, 950-7.
  12. Lopez-Morales D, Velazquez-Marquez N, Valenzuela O, et al (2009). Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest Clin, 50, 45-53.
  13. Lopez-Morales D, Reyes-Leyva J, Santos-Lopez G, Zenteno E, Vallejo-Ruiz V (2010). Increased expression of sialic acid in cervical biopsies with squamous intraepithelial lesions. Diagnos Pathol, 74, 1-5.
  14. Milflores-Flores L, Millan-Perez L, Santos-Lopez G, Reyes-Leyva J, Vallejo-Ruiz V (2012). Characterization of P1 promoter activity of the ${\beta}$-galactoside ${\alpha}2,6sialyltransferase$ I gene (siat 1) in cervical and hepatic cancer cell lines. J Biosci, 37, 1-8. https://doi.org/10.1007/s12038-011-9168-0
  15. Mullan PB, Quinn JE, Harkin DP, (2006). The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene, 25, 5854-63. https://doi.org/10.1038/sj.onc.1209872
  16. Roy A, Chakraborty S, (2005). Detection of cancer cervix by estimation of sialic acid. J Indian Med Assoc, 103, 589-90.
  17. Sellers TA, Huang Y, Cunningham J, et al (2008). Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev, 17, 397-404. https://doi.org/10.1158/1055-9965.EPI-07-0565
  18. Stanczuk GA, Sibanda EN, Perrey C, et al (2001). Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer, 94, 792-4. https://doi.org/10.1002/ijc.1543
  19. Taniguchi A, Matsumoto K, (1998). Down-regulation of human sialyltransferase gene expression during in vitro human keratinocyte cell line differentiation. Biochem Biophys Res Commun, 243, 177-83. https://doi.org/10.1006/bbrc.1998.8078
  20. Taniguchi A, Matsumoto K (1999). Epithelial-cell-specific transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene. Biochem Biophys Res Commun, 257, 516-22. https://doi.org/10.1006/bbrc.1999.0509
  21. Taniguchi A, Hioki M, Matsumoto K (2003). Transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1, 4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene in testis and ovary cell lines. Biochem Biophys Res Commun, 301, 764-8. https://doi.org/10.1016/S0006-291X(03)00041-X
  22. Velazquez-Marquez N, Santos-Lopez G, Jimenez-Aranda L, Reyes-Leyva J, Vallejo-Ruiz V (2012). Sialyl Lewis x expression in cervical scrapes of premalignant lesions. J Biosci, 37, 1-6. https://doi.org/10.1007/s12038-011-9168-0
  23. Wang PH, Li YF, Juang CM, et al, (2002). Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis. Gynecol Oncol, 86, 45-52. https://doi.org/10.1006/gyno.2002.6714
  24. Wang PH, Lee WL, Lee YR, et al (2003). Enhaced expression of ${\alpha}2,6$-sialyltransferase ST6gal I in cervical squamous cell carcinoma. Gynecol Oncol, 89, 395-401. https://doi.org/10.1016/S0090-8258(03)00127-6
  25. Wang X, Vertino A, Eddy RL, et al (1993). Chromosome mapping and organization of the human ${\beta}$-galactoside ${\alpha}2,6$ sialyltrans ferase Gene. J Biol Chem, 268, 4355-61.
  26. Williams T, Tjian R (1991). Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev, 5, 670-82. https://doi.org/10.1101/gad.5.4.670
  27. Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A (2009). CD83 polymorphisms and cervical cancer risk. Gynecol Oncol, 114, 319-22. https://doi.org/10.1016/j.ygyno.2009.04.033
  28. Zhang Z, Borecki I, Nguyen L, et al (2007). CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. Cancer Res, 67, 11202-8. https://doi.org/10.1158/0008-5472.CAN-07-2677
  29. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD (2001). Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem, 276, 40755-60. https://doi.org/10.1074/jbc.M106284200

Cited by

  1. 'Drawing' a Molecular Portrait of CIN and Cervical Cancer: a Review of Genome-Wide Molecular Profiling Data vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4477